Search results
Found 1080 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
COVID-19’s high blood clot risk
Coronavirus COVID-19 General Research
14 May 2022
A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.
Medical Sciences Division receives REF 2021 results
General Research
12 May 2022
Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021. REF is the UK-wide assessment of research in universities, and provides an expert evaluation of the quality of the research outputs, impact and environment at subject level in each university.
Oxford researchers part of major UK initiative to understand chronic pain
General Research
10 May 2022
Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.
Neither detection nor control of high blood pressure improved by self-monitoring during pregnancy
General Research
4 May 2022
Self-monitoring of blood pressure during pregnancy neither results in earlier detection of high blood pressure, nor helps with blood pressure control in those who are pregnant, suggest the results of two new papers based on research from the University of Oxford and King’s College London (funded by the National Institute of Health and Care Research).
Breakthrough in treatment for Dupuytren’s disease
Clinical Trials General Research
30 April 2022
Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.
How to use the science of the body clock to improve our sleep and health
General Research
28 April 2022
Jacqueline Pumphrey, April 2022
Paediatric IBD BioResource opens to support vital research
General Research
28 April 2022
A new National Institute for Health and Care Research (NIHR) BioResource aimed at investigating inflammatory bowel disease (IBD) in children has opened, with the NIHR Oxford BRC playing a key role.
Endometriosis: pandemic backlog risks making it even harder for women to get help
General Research
27 April 2022
World Malaria Day 2022
Clinical Trials General Research
25 April 2022
Patient recruitment is on-track in the Oxford-led DeTACT trial of safe, effective drug combinations to prevent the spread of artemisinin and multi-drug resistant malaria in Africa.
MRC National Mouse Genetics Network Research Clusters Announced
Awards and Appointments General Research
19 April 2022
Unique Oxford study of vascular disease reaches 20th anniversary
General Research
14 April 2022
The only project of its kind anywhere that studies patients with all types of acute vascular events – including strokes, heart attacks, aneurysms – in order to develop better diagnostic tests and treatments celebrates its 20th anniversary this month.
Protease inhibitors safer than thought for pregnant women with HIV
General Research
13 April 2022
University of Oxford researchers assessed evidence from 34 studies, involving over 57,000 pregnant women with HIV, and found that protease inhibitor-based antiretroviral therapies significantly increased the risk of babies being small or very small for their gestational age, but there were no other adverse pregnancy outcomes, compared to therapies without protease inhibitors.
Diagnostic test could offer new hope for ME/CFS patients
General Research
13 April 2022
Myalgic Encephalomyelitis /Chronic Fatigue Syndrome (ME/CFS) is a chronic condition without a diagnostic test and some 80 - 90% of patients remain un-diagnosed. A new paper published in Frontiers in Medicine outlines how having a diagnostic test could greatly help both patients and medics.
Expansion of the Oxford Joint Research Office
General Research
8 April 2022
Oxford’s Joint Research Office (JRO) has expanded to include teams from Oxford Health (OH) NHS Foundation Trust and Oxford Brookes University (OBU), joining the clinical research support teams from the University of Oxford (OU) and Oxford University Hospitals (OUH) NHS Foundation Trust.
An unexpected role for the cell’s largest membrane network
General Research
7 April 2022
A new Klemm Lab-led paper has uncovered a new mechanism involving the endoplasmic reticulum that is critical to the organisation and position of the microtubule (MT) cytoskeleton, which ultimately dictates the shape and function of our body’s cells.
Oxford spin-out Optellum attains CE marking for its early lung cancer diagnosis AI technology
General Innovation Research
6 April 2022
The contribution of individual features on clinical imaging scans to the performance of the LCP-CNN cancer risk prediction model developed in Oxford was investigated.
New research suggests targeting blood vessels could be key to controlling fibrotic disease
General Research
1 April 2022
By studying blood vessels at single cell resolution, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) Professor Jagdeep Nanchahal and colleagues found that in Dupuytren’s disease, a fibrotic disorder of the hand, the vasculature is key to orchestrating the development of human fibrosis.
AI helps to detect bone fractures to 92% accuracy
General Research
31 March 2022
Research from the Botnar Institute for Musculoskeletal Sciences shows that Artificial Intelligence (AI) is an effective tool for fracture detection that has potential to aid clinicians in busy emergency departments.
Defining the role of resident memory B cells in the fight against influenza
General Research
31 March 2022
Researchers at the Kennedy Institute of Rheumatology have used 3D and live-imaging to show how resident memory B cells boost antibodies to fight influenza.
No increased risk of brain tumours for mobile phone users, new study finds
General Research
30 March 2022
Longstanding fears that using mobile phones may increase the risk of developing a brain tumour have been reignited recently by the launch of 5G (fifth generation) mobile wireless technologies. Mobile phones emit radiofrequency waves which, if absorbed by tissues, can cause heating and damage.